Clinical review: Growth hormone and cardiovascular risk factors.
about
GH and the cardiovascular system: an update on a topic at heartGrowth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor IHormone replacement therapy and physical function in healthy older men. Time to talk hormones?Adipokine profile and urinary albumin excretion in isolated growth hormone deficiencyRole of Growth Hormone Deficiency and Treatment in Chronic Kidney DiseaseThe prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic ringsCardiovascular risk in aging and obesity: is there a role for GH.Brazilian adult individuals with untreated isolated GH deficiency do not have accelerated subclinical atherosclerosis.Adult growth hormone deficiency: to treat or not to treat.Growth hormone, insulin-like growth factors, and the skeleton.Easypod: a new electronic injection device for growth hormone.MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.Hypopituitarism and brain injury: recent advances in screening and management.Hormones as doping in sports.Glucocorticoids and the regulation of growth hormone secretion.The metabolic effects of growth hormone in adipose tissue.Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Diabetes in Cushing Disease.One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention.Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study.The effect of recombinant human growth hormone therapy on left-ventricular chamber size and function in children with growth hormone deficiency.Low prevalence of growth hormone deficiency in Turkish patients with Hashimoto's thyroiditis.[Long time consequences of the growth hormone deficiency].GH replacement reduces increased lipid peroxidation in GH-deficient adults.Hypopituitarism 3 and 12 months after traumatic brain injury and subarachnoid haemorrhage.Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury.Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.Cardiac functions in children with growth hormone deficiency before and during growth hormone-replacement therapy.Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.Lifetime, untreated isolated GH deficiency due to a GH-releasing hormone receptor mutation has beneficial consequences on bone status in older individuals, and does not influence their abdominal aorta calcification.
P2860
Q27002329-4B6A5C3D-9BA7-4D3C-B84D-5D4DCCEDE0A7Q30439933-6B2A7929-7240-4B5A-BE75-015F327E0228Q33569163-3A3F1163-DD72-452F-9D81-866A07CA2EB1Q33736161-E72EF6F1-5310-40C8-80B9-38341998F3ACQ35149805-2076443D-F0A6-420E-9181-69183FC25FC4Q35578519-1E402FE0-A791-4C9D-ABB7-4DB89D50692AQ36309188-72553B1D-0D08-4193-86F5-E2017174C621Q36536001-931957BC-34B5-4F2E-B195-2C68628F18ECQ36787300-0CADB06C-6D8D-417F-A12F-55F2265BE1EDQ37147591-AF0BE923-C481-4281-A2FC-546213D33D7AQ37152832-9F517970-54FC-4E2D-8A39-96D5F8A28024Q37626107-D8DB5BA3-8762-4782-8F18-6DCE130C1D0BQ37800372-F274B20A-A054-4F50-A014-786FA283967EQ38044615-000A1550-2C37-4814-B997-74DAF4F2DCA5Q38079133-F0DEACB1-B5C0-467C-93C1-29E3234CB1D4Q38083594-2CE9C64F-0E1E-4EC1-A8A3-12B6EBF44174Q38210878-0F0891D5-C4AA-445A-91CD-EFF522948DCCQ38683309-22C4385B-430E-4FE8-B479-86EFFAD0313DQ39212408-8E758EE0-CB5E-4B3A-80E7-C45B71B6BA70Q39852966-437B3F02-E0CD-4939-9753-AFC5470D17F1Q40179094-47D61650-EE7B-47EB-9AFB-F0E976D3EBC8Q44466662-E3D14ECF-D825-4587-BA52-32F1B381E497Q44715050-F8DDDAF0-F92C-47A7-A76F-AD26E44E3EA1Q45046850-B9A33DBB-3DF2-47F8-BB42-00C385D0E4F6Q46363166-8D462087-0C33-4D05-9698-3BC14F9125B1Q46887509-B263A263-20D7-4C58-A313-13BE9315DFB3Q47892857-094E0562-68AD-48AC-9C4E-7449C2578F1CQ48203743-9FF1F481-F184-44DB-B26B-3579D2AF22E7Q51357970-5E159676-ADE6-4BBB-97F3-684BCD06D29EQ51479966-CC2CC19F-D4D1-46B5-9AD5-A7B417FE3450Q51498823-BF2C9276-F2B7-4E8C-9475-9D783BC64F05Q54542044-ADDA6795-9E5A-45C8-AF05-C6DD4062C133
P2860
Clinical review: Growth hormone and cardiovascular risk factors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical review: Growth hormone and cardiovascular risk factors.
@ast
Clinical review: Growth hormone and cardiovascular risk factors.
@en
type
label
Clinical review: Growth hormone and cardiovascular risk factors.
@ast
Clinical review: Growth hormone and cardiovascular risk factors.
@en
prefLabel
Clinical review: Growth hormone and cardiovascular risk factors.
@ast
Clinical review: Growth hormone and cardiovascular risk factors.
@en
P2093
P356
P1476
Clinical review: Growth hormone and cardiovascular risk factors.
@en
P2093
Andrea Giustina
Mauro Doga
Monica Gola
Stefania Bonadonna
P304
P356
10.1210/JC.2004-0545
P407
P577
2004-12-07T00:00:00Z